ritanserin



ritanserin


SMILES Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1
InChIKey JUQLTPCYUFPYKE-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 5
Hydrogen bond donors 0
Rotatable bonds 5
Molecular weight (Da) 477.2

Database connections

Structure pdb 6BQH
Ligand site mutations 5-HT1A 5-HT2A 5-HT2C 5-HT6


No bioactivity data available.

ritanserin


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV

Database connections

Structure pdb 6BQH
Ligand site mutations 5-HT1A 5-HT2A 5-HT2C 5-HT6


Compound is not listed as a drug.